Clinical Research Fellow in Translational Oncology
at University College London
London, England, United Kingdom -
Start Date | Expiry Date | Salary | Posted On | Experience | Skills | Telecommute | Sponsor Visa |
---|---|---|---|---|---|---|---|
Immediate | 26 Jul, 2024 | Not Specified | 28 Jun, 2024 | 1 year(s) or above | Good communication skills | No | No |
Required Visa Status:
Citizen | GC |
US Citizen | Student Visa |
H1B | CPT |
OPT | H4 Spouse of H1B |
GC Green Card |
Employment Type:
Full Time | Part Time |
Permanent | Independent - 1099 |
Contract – W2 | C2H Independent |
C2H W2 | Contract – Corp 2 Corp |
Contract to Hire – Corp 2 Corp |
Description:
ABOUT US
The UCL Cancer Institute (https://www.ucl.ac.uk/cancer/) is a state-of-the-art institute to consolidate cancer research at UCL and promote links with our partner teaching hospitals, in order to support excellence in basic and translational studies.
The Treatment Resistance Team at the CI, led by Prof Gerhardt Attard, focuses on studying treatment resistance in advanced urological cancers and has been integrating circulating cell-free DNA, tumour tissues and single-cell technologies with functional studies to track tumour clone dynamics in patients progressing through multiple lines of treatment. Some of the group’s work involves collecting biological samples from several trials, including STAMPEDE - a multi-arm, multistage, randomised-controlled platform trial that has recruited more than 10,000 patients since 2005.
THE POST WILL BE APPOINTED ON ONE OF THE SCALES INCLUDING IN THE JOB DESCRIPTION, DEPENDING ON EXPERIENCE AND IS AVAILABLE FOR ONE YEAR IN THE FIRST INSTANCE.
An acceptable DBS check is required to carry out this role.
Responsibilities:
ABOUT THE ROLE
The main objective of this post will be to coordinate the collection, processing, and analysis of clinical, imaging and biopsy data from the ReIMAGINE study. As such, the postholder will hold honorary contracts across all ReIMAGINE sites (University College London Hospital, the Royal Free Hospital and Charing Cross Hospital). Overall responsibility for the postholder will be with the UCL Treatment Resistance Team.
This appointment would suit foundation, core medical or core surgical trainees considering a career in oncology, urology, radiology or pathology or specialist trainees prior to undertaking a MD/PhD. We have a strong track record in helping trainees gain their subsequent chosen positions including national training numbers, consultant posts and industry roles.
As well as the exciting opportunities this role presents we also offer some great benefits some of which are below:
- 41 Days holiday (including 27 days annual leave 8 bank holiday and 6 closure days)
- Defined benefit career average revalued earnings pension scheme (CARE)
- Cycle to work scheme and season ticket loan
- On-Site nursery
- On-site gym
- Enhanced maternity, paternity and adoption pay
- Employee assistance programme: Staff Support Service
- Discounted medical insurance
REQUIREMENT SUMMARY
Min:1.0Max:6.0 year(s)
Hospital/Health Care
Pharma / Biotech / Healthcare / Medical / R&D
Health Care
Graduate
Proficient
1
London, United Kingdom